Bilcare Ltd

Bilcare Ltd share price gained 3.72% to Rs 81.73 after the company's net profit plunged by 92.85% to Rs 1.07 crore, while revenue from operations improved marginally 9.99% to Rs 248.43 crore in Q3FY26 over Q2FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 42882.81 crore, easing 7.90%. It has slipped by 0.44% over last one week and eased lower by 1.93% in last one month while the market capitalization of Bilcare Ltd has marginally improved by 0.75% and 31.83% in the same period respectively. Profit before tax (PBT) of Bilcare Ltd stood at Rs 1.98 crore in Q3 FY26, tanking 111.91% year-on-year, and nosediving by 86.66% quarter-on-quarter. EBITDA came in at Rs 19 crore, tumbling by 2186.67% YoY and plunging by 46.75% sequentially. Total expenses increased by 19.33% to Rs 230.25 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 167.05 crore, going up by 17.08% YoY, while employee benefits expense was at Rs 22.54 crore, jumping 14.01% YoY. For the TTM ended FY26, revenue from operations declined slightly by 6.92% to Rs 733.54 crore, while net profit witnessed a sharp fall of 38.54% to Rs 17.29 crore, compared to previous TTM. EBITDA soared by 2774% to Rs 14.43 crore, and PBT collapsed by 50.45% to Rs 21.46 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 127.79 crore in FY26, as against Rs 84.99 crore in FY25. Bilcare Ltd tumbled by 21.15% in last one year, underperforming the benchmark BSE Sensex which has eased by 8.41% during the same period.

Bilcare Limited will hold a board meeting on Tuesday, November 3, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, according to a regulatory filing with the Bombay Stock Exchange. The trading window for the company’s securities is closed from Thursday, October 1, 2026, until 48 hours after the financial results are declared.

Bilcare Limited informed the Bombay Stock Exchange that Mr. Mohan Bhandari and Mrs. Kavita Bhansali will continue as Non-Executive Non-Independent Director & CEO and Non-Executive Non-Independent Director, respectively, after special resolutions proposed at the company’s 39th Annual General Meeting held on September 26, 2026, were not passed by the requisite majority.

Bilcare Limited informed the Bombay Stock Exchange that it is enclosing a certificate received from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited (Formerly Link Intime India Private Limited), for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Bilcare Limited will close its trading window for designated persons from October 1, 2026, until 48 hours after the declaration of the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Net profit of Bilcare declined 23.95% to Rs 13.37 crore in the quarter ended March 2026 as against Rs 17.58 crore during the previous quarter ended March 2025. Sales declined 3.28% to Rs 187.66 crore in the quarter ended March 2026 as against Rs 194.03 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 1.72 crore in the year ended March 2026 as against net loss of Rs 0.75 crore during the previous year ended March 2025. Sales declined 6.92% to Rs 733.54 crore in the year ended March 2026 as against Rs 788.04 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales187.66194.03 -3 733.54788.04 -7 OPM %9.023.96 -6.065.78 - PBDT13.70-3.63 LP 2.09-19.15 LP PBT8.92-8.29 LP -17.66-37.27 53 NP13.3717.58 -24 1.72-0.75 LP Powered by Capital Market - Live

Bilcare will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net Loss of Bilcare reported to Rs 5.95 crore in the quarter ended December 2025 as against net loss of Rs 7.16 crore during the previous quarter ended December 2024. Sales declined 8.48% to Rs 181.32 crore in the quarter ended December 2025 as against Rs 198.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales181.32198.13 -8 OPM %7.185.38 - PBDT1.11-5.38 LP PBT-10.82-17.12 37 NP-5.95-7.16 17 Powered by Capital Market - Live

Bilcare will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live

Net Loss of Bilcare reported to Rs 12.36 crore in the quarter ended September 2025 as against net loss of Rs 16.03 crore during the previous quarter ended September 2024. Sales declined 11.67% to Rs 178.20 crore in the quarter ended September 2025 as against Rs 201.74 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales178.20201.74 -12 OPM %1.923.79 - PBDT-11.32-12.12 7 PBT-23.55-23.16 -2 NP-12.36-16.03 23 Powered by Capital Market - Live